Loading...

BEAM BEAM THERAPEUTICS INC Company Mergers 8-K Filing

BM T

BM

BEAM THERAPEUTICS INC

(BEAM)

2025 8-K

Asset Acquisition Update

Financial Results Announced

Asset Acquisitions

Positive Trial Data

Financial Results

Financial Update

Clinical Trial Updates

Management Change

Board Expansion

Clinical Trial Updates

Financial Results

Earnings Reports

Resignation and Appointment

Annual Meeting Voting Results

Earnings Reports

Earnings Reports

Financial Update

Board Expansion and New Dir...

Financial Results Announcement

Completion of Acquisition o...

Costs Associated with Exit ...

Financial Results Announcement

Annual Meeting Voting Results

Agreement with Jefferies LLC

Earnings Reports

Financial Results Announcement

Financial Results

External Links:

On December 8, 2025, Beam Therapeutics Inc. converted its 75 million shares in Orbital Therapeutics into $255.1 million in cash, with up to an additional $26.3 million possible. This acquisition by Bristol-Myers Squibb impacts Beam's future cash runway plans, which will be discussed at the 2026 J.P. Morgan Healthcare Conference.

AI Assistant

BEAM THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.